Novel antibody selective for soluble aggregated

ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse fashions of Parkinson’s illness A rising physique of proof means that aggregated α-synuclein, the foremost constituent of Lewy our bodies, performs a key position within the pathogenesis of Parkinson’s illness and associated α-synucleinopathies. Immunotherapies, each lively and passive,…

Read More